Table 1. Sample information for all coeliac individuals and controls sequenced in this study.

Characteristic		Median or n	% †	Range
	Coeliac individuals				anti-CD3/CD28	PMA	Unstimulated
Age, n 15		57.0		22–75	15	14	13
Females/Males, n 15		11/4	73.3/26.7
Diagnosis age, n 15		39.0		0.5–70
Diagnosis by age range, n 15	< 18 years	5	33.3
	≥18–35 years	2	13.3
	>35–55 years	5	33.3
	>55	3	20.0
Clinical presentation at diagnosis *, n 12	Classical CD	9	75.0
	Non-classical CD	2	16.7
	Subclinical CD	1	8.3
Family history of coeliac disease, n 15	Yes	5	33.3
	No	10	66.7
Family history of other autoimmune disease, n 15	Yes	5	33.3
	No	10	66.7
Presence of other autoimmune diseases, n 15	Yes	4	26.7
	No	11	73.3
	Control individuals
Age, n 11		50.0		40–70	11	11	10
Females/Males, n 11		7/4	63.6/36.3

* Clinical presentation at diagnosis was classified according to the Oslo definition of CD into; Classical, Non-classical and Subclinical

^† Percentages provided are valid percentages